Genetic variability of Polish serogroup B meningococci (2010-2016) including the 4CMenB vaccine component genes.
Sign Up to like & getrecommendations! Published in 2020 at "Vaccine"
DOI: 10.1016/j.vaccine.2020.01.021
Abstract: Neisseria meningitidis serogroup B (MenB) has recently become the major cause of invasive meningococcal disease in Poland. Therefore, the purpose of this study was to characterize MenB isolates, responsible for invasive meningococcal disease in 2010-2016,… read more here.
Keywords: meningococci 2010; 2010 2016; coverage; 4cmenb vaccine ... See more keywords
Synergistic activity of antibodies in the multicomponent 4CMenB vaccine
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Vaccines"
DOI: 10.1080/14760584.2022.2050697
Abstract: ABSTRACT Introduction Vaccines based on multiple antigens often induce an immune response, which is higher than that triggered by each single component, with antibodies acting cooperatively and synergistically in tackling the infection. Areas covered An… read more here.
Keywords: multicomponent 4cmenb; synergistic activity; activity antibodies; activity ... See more keywords
An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10020309
Abstract: Invasive meningococcal disease (IMD) causes significant morbidity and mortality worldwide with serogroup B being the predominant serogroup in Australia and other countries for the past few decades. The licensed 4CMenB vaccine is effective in preventing… read more here.
Keywords: meningococcal disease; 4cmenb vaccine; carriage; study ... See more keywords